Monte Rosa Therapeutics Balance Sheet
NASDAQ: GLUEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Monte Rosa Therapeutics financial position
At the end of fiscal 2025, Monte Rosa Therapeutics reported total assets of $448.7 million, up 2.3% from a year earlier against total liabilities of $215.6 million. Shareholders' equity stood at $233.1 million, or 51.9% of assets. The company held $129.9 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 6.12, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Monte Rosa Therapeutics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 129.88M | 224.25M | 128.10M | 54.91M | 346.07M | 41.70M |
| Total Current Assets | 393.19M | 377.44M | 236.21M | 275.89M | 348.67M | 43.59M |
| Property, Plant & Equipment | 25.99M | 29.48M | 33.80M | 27.07M | 12.32M | 4.62M |
| Total Assets | 448.66M | 438.73M | 303.75M | 342.39M | 366.33M | 49.38M |
| Accounts Payable | 3.55M | 17.21M | 11.15M | 7.86M | 6.56M | 7.07M |
| Total Current Liabilities | 64.21M | 156.95M | 46.59M | 25.57M | 16.64M | 29.27M |
| Total Liabilities | 215.60M | 215.80M | 124.50M | 70.98M | 18.81M | 30.34M |
| Shareholders' Equity | 233.06M | 222.94M | 179.25M | 271.41M | 347.51M | -48.73M |
| Retained Earnings | -477.21M | -438.59M | -365.89M | -230.54M | -122.03M | -48.08M |
| Net Cash (Debt) | 129.88M | 224.25M | 128.10M | 54.91M | 346.07M | 41.70M |
| Shares Outstanding | 65.54M | 61.51M | 50.14M | 49.32M | 46.54M | 1.69M |
This table shows 6 annual periods of Monte Rosa Therapeutics's balance sheet, from FY 2025 back to FY 2020, across 11 line items including cash & equivalents, total current assets, property, plant & equipment. Values in USD; B = billions, M = millions. Fiscal periods follow GLUE's reporting calendar. What is a balance sheet?